ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,796Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 559

$684K Total Retail Price of All Prescriptions

Rank: 16 out of 559

866 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 866 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 866 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,264 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 748 611 1 3
LEVOTHYROXINE SODIUM 651 522 2 2
LISINOPRIL 445 393 3 1
LOVASTATIN 360 302 4 10
OMEPRAZOLE 314 239 5 4
METOPROLOL SUCCINATE 288 246 6 16
AMLODIPINE BESYLATE 254 225 7 6
METFORMIN HCL 238 213 8 5
HYDROCODONE-ACETAMINOPHEN 219 131 S3 9 7
METOPROLOL TARTRATE 186 166 10 12
BACLOFEN 178 137 11 90
HYDROCHLOROTHIAZIDE 176 137 12 8
FLUTICASONE PROPIONATE 164 131 13 22
OXYCODONE HCL 158 75 S2 14 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 142 122 15 18
FUROSEMIDE 141 122 16 11
LOSARTAN POTASSIUM 132 128 17 14
CITALOPRAM HBR 132 107 17 21
TRAZODONE HCL 129 75 19 28
CRESTOR 128 121 20 33
PANTOPRAZOLE SODIUM 126 107 21 41
ALENDRONATE SODIUM 126 120 21 13
TRIAMTERENE-HYDROCHLOROTHIAZID 120 113 23 112
GABAPENTIN 116 64 24 9
ATORVASTATIN CALCIUM 115 108 25 20
DOXAZOSIN MESYLATE 114 103 26 43
ATENOLOL 107 91 27 15
FINASTERIDE 105 97 28 59
VERAPAMIL ER 105 92 28 89
GLIPIZIDE 105 89 28 31
SPIRIVA 103 89 31 67
ALLOPURINOL 102 102 32 34
ADVAIR DISKUS 101 79 33 46
CELEBREX 96 94 34 86
INSULIN SYRINGE 89 89 35 65
POTASSIUM CHLORIDE 89 62 35 23
VENTOLIN HFA 82 77 37 113
SERTRALINE HCL 82 57 37 19
NAMENDA 81 81 39 56
LANTUS 79 70 40 40
IBUPROFEN 77 51 41 30
TRIAMCINOLONE ACETONIDE 77 64 41 84
ENDOCET 73 31 S2 43 105
DIGOXIN 73 73 43 94
PROAIR HFA 72 52 45 29
TERAZOSIN HCL 69 69 46 82
DONEPEZIL HCL 64 64 47 36
BUPROPION HCL SR 64 45 47 114
MORPHINE SULFATE ER 64 26 S2 47 63
CARVEDILOL 61 48 50 38
DOXEPIN HCL 59 52 51 171
TAMSULOSIN HCL 59 49 51 25
PAROXETINE HCL 57 34 53 48
OXYBUTYNIN CHLORIDE 57 48 53 62
PREDNISONE 55 51 55 49
CYMBALTA 54 33 56 78
NAPROXEN 53 43 57 79
AMITRIPTYLINE HCL 52 29 R 58 58
TRAMADOL HCL 50 21 59 27
FLUOXETINE HCL 50 31 59 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.